Healthcare provider profile · identity verified

Patrick Mcgrath, MD

Family Practice · SPENCERPORT, NY · NPI 1932138526

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	653	211
Levothyroxine Sodium	Levothyroxine Sodium	545	124
Amlodipine Besylate	Amlodipine Besylate	390	114
Lisinopril	Lisinopril	307	101
Metformin Hcl Er	Metformin Hcl	268	84
Omeprazole	Omeprazole	259	83
Hydrochlorothiazide	Hydrochlorothiazide	254	82
Gabapentin	Gabapentin	237	65
Pantoprazole Sodium	Pantoprazole Sodium	237	64
Losartan Potassium	Losartan Potassium	233	71
Rosuvastatin Calcium	Rosuvastatin Calcium	191	60
Simvastatin	Simvastatin	182	52
Pravastatin Sodium	Pravastatin Sodium	179	53
Ozempic	Semaglutide	170	23
Irbesartan	Irbesartan	156	39
Metoprolol Succinate	Metoprolol Succinate	150	45
Sertraline Hcl	Sertraline Hcl	150	40
Potassium Chloride	Potassium Chloride	145	35
Fluticasone Propionate	Fluticasone Propionate	140	49
Tamsulosin Hcl	Tamsulosin Hcl	126	35
Albuterol Sulfate Hfa	Albuterol Sulfate	118	49
Jardiance	Empagliflozin	116	26
Pioglitazone Hcl	Pioglitazone Hcl	115	35
Carvedilol	Carvedilol	112	32
Eliquis	Apixaban	108	25
Metformin Hcl	Metformin Hcl	105	29
Famotidine	Famotidine	101	27
Ezetimibe	Ezetimibe	91	28
Trazodone Hcl	Trazodone Hcl	91	28
Pregabalin	Pregabalin	89	12
Duloxetine Hcl	Duloxetine Hcl	85	19
Zolpidem Tartrate	Zolpidem Tartrate	83	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	22
Metoprolol Tartrate	Metoprolol Tartrate	80	26
Venlafaxine Hcl Er	Venlafaxine Hcl	77	11
Clonazepam	Clonazepam	76	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	21
Escitalopram Oxalate	Escitalopram Oxalate	71	25
Atenolol	Atenolol	69	22
Warfarin Sodium	Warfarin Sodium	68	14
Furosemide	Furosemide	67	28
Glimepiride	Glimepiride	66	22
Prednisone	Prednisone	64	27
Mirtazapine	Mirtazapine	60	12
Torsemide	Torsemide	59	20
Januvia	Sitagliptin Phosphate	57	suppressed
Allopurinol	Allopurinol	56	20
Citalopram Hbr	Citalopram Hydrobromide	56	19
Clopidogrel	Clopidogrel Bisulfate	56	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	suppressed
Tramadol Hcl	Tramadol Hcl	54	13
Carnitor	Levocarnitine	53	suppressed
Ipratropium Bromide	Ipratropium Bromide	53	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	suppressed
Spironolactone	Spironolactone	49	17
Alendronate Sodium	Alendronate Sodium	47	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	47	15
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	12
Lovastatin	Lovastatin	44	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	18
Bisoprolol Fumarate	Bisoprolol Fumarate	42	13
Montelukast Sodium	Montelukast Sodium	42	12
Doxycycline Hyclate	Doxycycline Hyclate	41	36
Amoxicillin	Amoxicillin	38	26
Celecoxib	Celecoxib	38	17
Felodipine Er	Felodipine	38	13
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Cefdinir	Cefdinir	36	30
Lorazepam	Lorazepam	35	16
Meloxicam	Meloxicam	34	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Ramipril	Ramipril	33	12
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	18
Glipizide Er	Glipizide	30	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	30	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	29	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Methylprednisolone	Methylprednisolone	27	26
Aripiprazole	Aripiprazole	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Azithromycin	Azithromycin	21	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Methadone Hcl	Methadone Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Ondansetron Odt	Ondansetron	20	11
Xarelto	Rivaroxaban	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Synthroid	Levothyroxine Sodium	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Acyclovir	Acyclovir	17	suppressed
Morphine Sulfate	Morphine Sulfate	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Mupirocin	Mupirocin	16	12
Nystatin	Nystatin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valsartan	Valsartan	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ramelteon	Ramelteon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error